孕妇接种百日咳疫苗及未接种者所生婴儿免疫应答影响因素:个体参与者数据荟萃分析
该个体参与者数据荟萃分析纳入8项研究,分析孕妇接种Tdap或未接种所生婴儿免疫后IgG水平的影响因素。结果显示,基础免疫前较高IgG水平与基础免疫后及加强免疫后某些抗原IgG水平降低相关,但孕期接种时机和婴儿免疫间隔不影响免疫后水平。
要点
- 基础免疫前IgG水平较高与基础免疫后某些抗原IgG水平降低相关。
- 孕期接种时机和婴儿免疫间隔不影响基础免疫后或加强免疫后抗体水平。
- 上述关联的临床意义尚不确定。
核心结论
- 基础免疫前IgG水平升高与孕妇接种或未接种所生婴儿基础免疫后及加强免疫后某些抗原IgG水平降低相关,但临床意义不确定。
研究设计与样本
- 个体参与者数据荟萃分析,纳入8项报告婴儿免疫后疫苗抗原IgG水平的研究,使用混合效应模型。
主要发现
- 在Tdap免疫孕妇所生婴儿中,基础免疫前抗PT和抗DT IgG水平高2倍与基础免疫后水平分别低9%和10%相关(GMR PT:0.91,95%CI 0.88-0.95,n=494;DT:0.9,0.87-0.93,n=519)。
- 在Tdap免疫孕妇所生婴儿中,基础免疫前抗PT和抗FHA IgG水平高2倍与加强免疫后水平降低相关(GMR PT:0.91,0.85-0.97,n=224;FHA:0.92,0.85-0.99,n=232)。
- 在未免疫孕妇所生婴儿中,基础免疫前某些疫苗抗原IgG水平高2倍与基础免疫后水平低8-17%相关(GMR PT:0.92,0.88-0.97,n=373;FHA:0.88,0.85-0.92,n=378;PRN:0.84,0.81-0.88,n=367;TT:0.88,0.83-0.93,n=241;DT:0.83,0.79-0.87,n=278)。
- 在未免疫孕妇所生婴儿中,基础免疫前抗FHA IgG水平高2倍与加强免疫后水平低8%相关(GMR 0.92,95%CI 0.86-0.99,n=138)。
- 孕期免疫时机和婴儿免疫间隔不影响基础免疫后或加强免疫后抗百日咳、抗TT和抗DT IgG水平。
临床怎么用
- 应关注婴儿基础免疫前IgG水平对免疫后应答的潜在影响,但当前证据尚不足以改变免疫策略。
局限性
- 研究未明确临床意义,且为观察性数据的荟萃分析,可能存在混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exploring factors that affect immune responses to immunizations in infants born to women immunized with tetanus-diphtheria-acellular-pertussis (Tdap) in pregnancy compared with unimmunized women is important in designing immunization programs. METHODS: Individual-participant data meta-analysis of 8 studies reporting post-immunization immunoglobulin G (IgG) levels to vaccine antigens in infants born to either women immunized with Tdap in pregnancy or unimmunized women, using mixed-effects models. RESULTS: In infants of Tdap-immunized women, two-fold higher levels of anti-pertussis toxin (PT) and anti-diphtheria-toxoid (DT) IgG pre-primary immunization were associated with 9% and 10% lower post-primary immunization levels, (geometric mean ratio [GMR], PT: 0.91; 95% CI, 0.88-0.95,n = 494, DT: 0.9; 0.87-0.93,n = 519). Timing of immunization in pregnancy did not affect post-primary immunization anti-Bordetella pertussis, anti-tetanus-toxoid (TT) and anti-DT IgG levels. Spacing of infant immunization did not affect post-primary immunization anti-B. pertussis and anti-DT levels. In infants of Tdap-immunized women, two-fold higher levels of anti-PT and anti-filamentous haemagglutinin (FHA) IgG pre-primary immunization were associated with lower post-booster immunization levels, (GMR, PT: 0.91; 0.85-0.97,n = 224, FHA: 0.92; 0.85-0.99,n = 232). Timing of immunization in pregnancy did not affect post-booster immunization anti-Bordetella pertussis, anti-tetanus-toxoid (TT) and anti-DT IgG levels. Spacing of infant immunization did not affect post-booster immunization anti-PT, anti-pertactin (PRN), anti-TT and anti-DT IgG levels. In infants of unimmunized women, two-fold higher IgG levels of some vaccine antigens pre-primary immunization were associated with 8-17% lower post-primary immunization levels (GMR, PT 0.92, 95% CI:0.88-0.97, n = 373; FHA:0.88, 95% CI:0.85-0.92,n = 378; PRN:0.84, 95% CI:0.81-0.88, n = 367; TT:0.88, 95% CI:0.83-0.93, n = 241; DT: 0.83, 95% CI:0.79-0.87,n = 278). Two-fold higher levels of anti-FHA IgG pre-primary immunization were associated with 8% lower post-booster immunization levels (GMR, 0.92; 95% CI: 0.86-0.99,n = 138). DISCUSSION: Increased IgG levels pre-primary immunization is associated with reduced post-primary and post-booster immunization levels for some antigens in infants of women immunized or unimmunized in pregnancy, but their clinical significance is uncertain.
引用
- Abu-Raya B, Maertens K, Munoz FM, et al. Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis. Vaccine. 2021. PMID: 34598822. doi:10.1016/j.vaccine.2021.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。